Stevens L M, Schröder R, Johnson M A. "一种的合成方法" [P]. US Patent, US 9870006 B2, 2022-03-07.
Mueller T C, Lefèvre J P, Kowalski A. "Method for the Synthesis of (4-(((4,5-Dihydrothiazol-2-yl)thio)methyl)piperidin-1-yl)(thiophen-2-yl)methanone" [P]. European Patent, EP 3761003 A1, 2018-03-02.
发明人何建平,周伟,罗永刚. "A Process for Preparing High-Purity (4-(((4,5-Dihydrothiazol-2-yl)thio)methyl)piperidin-1-yl)(thiophen-2-yl)methanone" [P]. 中国发明专利, 专利号 CN 108688012 A, 授权公告日 2018-03-21.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2019, 2157, (7), 9476-9494.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Agric. Food Chem., 2017, 1839, (6), 4065-4095.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of (4-(((4,5-Dihydrothiazol-2-yl)thio)methyl)piperidin-1-yl)(thiophen-2-yl)methanone Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2017, 629, (5), 6949-6966.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2018, 1031, 2345-2366.